glp-1 news november 3 2025 The Underappreciated Benefits of Receptor Agonists Novo cuts GLP-1 prices 70%,
Description
The front-facing outcome
doi: 10.1038/ijo.2011.158
Effects of sitagliptin therapy on markers of low-grade inflammation and cell adhesion molecules in patients with type 2 diabetes
Food no longer dominates their thoughts
Diabetes, obesity & metabolism, 27 Suppl 2(Suppl 2), 6688.
The fate of taspoglutide, a weekly GLP-1 receptor agonist, versus twice-daily exenatide for type 2 diabetes: the T-emerge 2 trial
